Antihypertensive effects of ACE2 in the paraventricular nucleus: A consequence of reduced neuroinflammation?

Cardiovascular Research

Volumn 92, Issue 3, 2011, Pages 365-366

  Grisk, Olaf ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 5; ANGIOTENSIN 6; ANGIOTENSIN 7; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II [3-8]; ANGIOTENSIN III; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; EDITORIAL; EXPERIMENTAL RAT; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS NUCLEUS; INFLAMMATION; KIDNEY DENERVATION; NEUROENDOCRINE SYSTEM; NEUROINFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC TONE; TRANSGENIC MOUSE;

ANGIOTENSIN II; ANIMALS; GENETIC THERAPY; HUMANS; HYPERTENSION; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PEPTIDYL-DIPEPTIDASE A;

EID: 81055147121     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr269     Document Type: Editorial

References (15)

1. Marvar P, Lob H, Vinh A, Zarreen F, Harrison DG. The central nervous system and inflammation in hypertension. Curr Opinion Pharmacol 2011;11:156-161.
2. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C et al. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 2010;107: 263-270.
3. Harris MC, Loewy AD. Neural regulation of vasopressin-containing hypothalamic neurons and the role of vasopressin in cardiovascular function. In: Loewy AD, Spyer KM, eds. Central Regulation of Autonomic Functions. New York: Oxford University Press 1990. p224-246.
4. Coote JH. A role of the paraventricular nucleus of the hypothalamus in the autonomic control of the heart and kidney. Exp Physiol 2005;90:169-173. (Pubitemid 40364794)
5. Pyner S, Coote JH. Identification of branching paraventricular neurons of the hypothalamus that project to the rostroventrolateral medulla and spinal cord. Neuroscience 2000;100:549-556.
6. Ferrario CM, Averill DB, Brosnihan KB, Chappell MC, Diz DI, Gallagher PE et al. Angiotensin-(1-7). Its contributions to arterial pressure control mechanisms. Handb Exp Pharmacol 2004;163/I,478-518.
7. Gomes da Silva AQ, Sousa dos Santos RA, Fontes MAP. Blockade of endogenous angiotensin-(1-7) in the hypothalamic paraventricular nucleus reduces renal sympathetic tone. Hypertension 2005;46:341-348. (Pubitemid 41099167)
8. Sriramula S, Cardinale JP, Lazartigues E, Francis J. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc Res 2011;92:401-408.
9. Feng Y, Xia H, Cai Y, Halabi CM, Becker LK, Santos RAS et al. Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ Res 2010;106:373-382.
10. Kang Y-M, Ma Y, Zheng J-P, Elks C, Sriramula S, Yang Z-M et al. Brain nuclear factorkappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc Res 2009;82:503-512.
11. Kang Y-M, He R-L, Yang L-M, Qin D-N, Guggilam A, Elks C et al. Brain tumour necrosis factor-a modulates neurotransmitters in hypothalamic paraventricular nucleus in heart failure. Cardiovasc Res 2009;83:737-746.
12. Kang Y-M, Zhang Z-H, Xue B, Weiss RM, Felder RB. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol 2008;295:H227-H236.
13. Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, von Zastrow M et al. Control of synaptic strength by glial TNFa. Science 2002;295:2282-2285. (Pubitemid 34258846)
14. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T et al. Interleukin-1b enhances NMDA receptor-mediated intracellular calcium increase through activation of the src family of kinases. J Neurosci 2003;24: 8692-8700. (Pubitemid 37176649)
15. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Bohm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376: 1903-1909.